Repository logo
 

MYO6 is targeted by $\textit{Salmonella}$ virulence effectors to trigger PI3-kinase signaling and pathogen invasion into host cells

Accepted version
Peer-reviewed

Type

Article

Change log

Authors

Brooks, ABE 
Humphreys, D 
Singh, V 
Davidson, AC 
Arden, SD 

Abstract

To establish infections, Salmonella injects virulence effectors that hijack the host actin cytoskeleton and phosphoinositide signaling to drive pathogen invasion. How effectors reprogram the cytoskeleton network remains unclear. By reconstituting the activities of the Salmonella effector SopE, we recapitulated Rho GTPase-driven actin polymerization at model phospholipid membrane bilayers in cell-free extracts and identified the network of Rho-recruited cytoskeleton proteins. Knockdown of network components revealed a key role for myosin VI (MYO6) in Salmonella invasion. SopE triggered MYO6 localization to invasion foci, and SopE-mediated activation of PAK recruited MYO6 to actin-rich membranes. We show that the virulence effector SopB requires MYO6 to regulate the localization of PIP3 and PI(3)P phosphoinositides and Akt activation. SopE and SopB target MYO6 to coordinate phosphoinositide production at invasion foci, facilitating the recruitment of cytoskeleton adaptor proteins to mediate pathogen uptake.

Description

Keywords

infection, macropinocytosis, motor protein, rho GTPase, type 3 secretion system

Journal Title

Proceedings of the National Academy of Sciences of the United States of America

Conference Name

Journal ISSN

0027-8424
1091-6490

Volume Title

114

Publisher

National Academy of Sciences
Sponsorship
Medical Research Council (MR/M011771/1)
Medical Research Council (MR/K000888/1)
Medical Research Council (MR/L008122/1)
Medical Research Council (MR/N000048/1)
Wellcome Trust (101828/Z/13/Z)
This work was funded by Wellcome Trust Grant 101828/Z/13/Z (to V.K.), by Medical Research Council Grants MR/K000888/1 and MR/N000048/1 (to F.B.), MR/L008122/1 (to V.K.), and MR/M011771/1 (to D.H.), and by the Cambridge Isaac Newton Trust.